BioMarin announces global settlement with Ascendis over Yuviwel royalties
BioMarin says Ascendis will pay royalties to BioMarin on Yuviwel sales in the U.S., EU, Brazil and South Korea under a global settlement.
Story updates
06:00:39 AM UTC
SquawkNews
BioMarin Announces Global Settlement with Ascendis Pharma A/S; Ascendis Will Pay Royalties to BioMarin on Yuviwel Sales in U.S., EU, Brazil and South Korea
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.